The role of asymmetric and symmetric dimethylarginines in renal disease. - Wikidata - wikimedia - TriplyDB

The role of asymmetric and symmetric dimethylarginines in renal disease.

The role of asymmetric and symmetric dimethylarginines in renal disease.

http://www.wikidata.org/entity/Q37858880

about

Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections Nitric oxide synthase derangements and hypertension in kidney disease The role of drug transporters in the kidney: lessons from tenofovir Vascular effects of exercise training in CKD: current evidence and pathophysiological mechanisms Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease Relationship between lean body mass and serum renal biomarkers in healthy dogs Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in pomerania.Restoration of asymmetric dimethylarginine-nitric oxide balance to prevent the development of hypertension.Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria.Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients Endothelial dysfunction and brachial intima-media thickness: long term cardiovascular risk with claudication related to peripheral arterial disease: a prospective analysis.Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Cats.Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Dogs Dietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats.Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD.Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.Serum concentrations of symmetric dimethylarginine and creatinine in cats with kidney stones Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.Plasma metabolomic profiles in different stages of CKD.Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease.Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.Small Molecule Inhibitors of Protein Arginine Methyltransferases.Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2 Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Cardiovascular disease in chronic kidney disease: untying the Gordian knot.Role of asymmetrical dimethylarginine in the progression of renal disease.Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases.AGXT2: a promiscuous aminotransferase.Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

P2860

Q26782662-7957C7A3-7B37-4224-8774-3CFEE9237F1F Q26849234-7C921BE0-AEE7-4F0E-B5A7-76BACEFE57E1 Q26866489-15D48A47-6091-45E6-819C-78EF6FD4764E Q27021802-5B021F92-AD61-4BFD-A56E-BFA222CD89C0 Q28087272-74656A78-E8D2-4C38-848E-92D45313E0BF Q28601037-E9D92A84-3863-470D-B61A-BC977838D3CF Q28601638-21887B76-4AAB-45FE-A841-FEC7992627A5 Q33580586-6474F827-F45E-4003-8DA6-C160435E3E75 Q33599633-011DD008-3FA4-4FE8-9D20-6AC0D1DFD875 Q34072296-6AEADC93-3D25-4964-BBD7-35F2A2CEA283 Q34315639-EBA3E6BE-19DF-4E35-BA41-1DE0457ACF93 Q34556614-3E5F7C6D-C1DF-4167-85DE-B4A6B0F797DC Q34984003-6BDE2754-DA5D-4F70-9FA6-431B3A3C1239 Q35150499-0BFC8388-D01D-45C4-94EC-252AC528723F Q35607229-BC33656E-BDC0-4594-8031-46F87E4B0F6B Q35686992-C1AD4526-5D29-42B9-8CD0-A988E4930244 Q35818228-A8F5256E-39A9-447A-82D5-8BA0F91D2B98 Q35990048-5C973F0F-8D48-4EAB-B305-2D42C50A690D Q35992197-69E828A0-CFA3-485D-99C7-00811F2D1EBC Q36082389-B1B5170C-A12D-44E7-B6C6-A20717F20898 Q36091725-70EA8B12-1048-4FB9-ADDF-1DD7D8C337B7 Q36182184-EB784EDC-BD35-4843-ACC7-B3774A83D810 Q36260985-E79F08CB-A435-4E41-B6A0-F79E52F42944 Q36337929-AC5CF47D-9EC7-4156-9A2F-510FE6CE2FB5 Q36481807-6736F45C-5E59-4681-BAF7-F950BC8539FD Q36509293-196826E4-EA38-4570-AB8E-8C4E053B3127 Q36652795-A38C0E58-DDD1-413C-B2B8-B9022C32B6D9 Q36975461-1C9B1201-A6D6-41BF-AB7A-AA31A4D0A607 Q37015522-1A0AB2C4-A504-4BD3-B750-8D420DCB5846 Q37056442-0B521028-05CC-4062-9592-E2B80845C973 Q37345580-81BE1484-7417-4EF7-95AE-B184429F0536 Q37602513-A647FBC9-99EA-4C30-96A7-A2669395BD9A Q37646687-E3747AC2-0921-4AED-82DD-1BD0FBDA1FEF Q38016491-2ADDEFDC-3957-48A6-BB5D-62263366544E Q38025185-3BA53C82-AA26-431C-9EEC-FD1C7E4EF30E Q38046935-2CAF5253-3B6F-4383-A8AD-6E002B8845AD Q38112398-30BA5EE3-9FF4-4084-A2EC-E4691480CF74 Q38203518-20EEB485-00DE-42FC-A72B-F9D4CF6537CF Q38257983-11CD4D0E-7B7E-44C5-B5BE-13802AAC8040 Q38635782-5101F06E-ED28-443A-9413-000D9D7A5FF9

P2860

The role of asymmetric and symmetric dimethylarginines in renal disease.

http://www.wikidata.org/entity/Q37858880

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The role of asymmetric and symmetric dimethylarginines in renal disease.

@en

The role of asymmetric and symmetric dimethylarginines in renal disease.

@nl

type

label

The role of asymmetric and symmetric dimethylarginines in renal disease.

@en

The role of asymmetric and symmetric dimethylarginines in renal disease.

@nl

prefLabel

The role of asymmetric and symmetric dimethylarginines in renal disease.

@en

The role of asymmetric and symmetric dimethylarginines in renal disease.

@nl

P1433

Q37858880-206B0E64-3205-4B96-8474-DFF0B6EFC9F4

P1476

Q37858880-C1FE764D-6BBC-4ED7-AF65-023A2C884F99

P2093

Q37858880-1032E495-D589-4E7E-AD19-117F8EE56195

Q37858880-9597F47A-F5A2-4695-B695-3AF4C657C277

P2860

Q37858880-02E74F25-481C-4D07-8DAF-B2739260E38F

Q37858880-03A5B945-4B33-4162-A045-DDECBFF39AE3

Q37858880-0422A578-FCD0-4946-96C7-72C7DEE73BBF

Q37858880-04F61772-853B-41A0-BE48-B9D0FAFE2356

Q37858880-09D75DBA-8908-490F-A810-DA887C74A7AE

Q37858880-0FE7495F-2F71-492E-B424-49DEADDDC2D8

Q37858880-12EA0B84-8706-4C77-9C87-2C0FD3AB4FE4

Q37858880-14B5788B-50DC-4984-AB41-D660999E4D56

Q37858880-196DD105-5EB5-482E-AB1D-DAC2F3B7AB05

Q37858880-1C914C9F-3D18-45FF-99E4-B720FC793875

P2888

Q37858880-A5B22823-8142-4C32-8494-0C8134B923DC

P304

Q37858880-0C38DB13-FB5E-41A5-A45A-119F8446E74A

P31

Q37858880-FA22214F-3AAB-47E6-AFAE-47EC79FF93B2

P356

Q37858880-431A70BC-A0A7-452D-9386-5783094F6C45

P407

Q37858880-333204DF-1B47-483A-8A9C-2FA010F40A4B

P433

Q37858880-D7B1C426-C65C-4E0F-A239-557F66191DF8

P478

Q37858880-3C89261B-5BD9-4922-BB3F-295AEB1F788D

P577

Q37858880-490D20F2-6124-4FAE-9BC8-EA08A6C0AC9A

P6179

Q37858880-9C71425F-E386-40D7-81A4-DD101D5953EE

P698

Q37858880-3A952728-E7E9-49C9-88E2-E802A1BFAF9D

P356

P1433

Nature Reviews Nephrology

P1476

The role of asymmetric and symmetric dimethylarginines in renal disease.

@en

P2093

Edzard Schwedhelm

http://www.w3.org/2001/XMLSchema#string

Rainer H Böger

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

Disruption of methylarginine metabolism impairs vascular homeostasis

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis

Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases

Protein arginine methylation in mammals: who, what, and why

Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in de

Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.

Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.

P2888

P304

275-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEPH.2011.31

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020331026

http://www.w3.org/2001/XMLSchema#string

P698

21445101

http://www.w3.org/2001/XMLSchema#string